Skip to content

Neuroplasticity: all studies

Page 9 of 178: studies 81 to 90 of 1,772, newest first. Back to the neuroplasticity overview

Research

The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry

Engrami 2025 Mile Jevtić 1 citation

Psychedelics are psychoactive substances that cause changes in perception, state of consciousness, mood and numerous cognitive processes. The best known are lysergic acid diethylamide (LSD), N,N-dimethyltryptamine (DMT), psilocybin and mescaline. The main mechanism of action of psychedelics is agonism towards serotonin 5-HT2A receptors. In the middle of the 20th century, interest in the use of...

Mushroom bioactives—polysaccharides to psilocybin: a viewpoint on the therapeutic use of mushrooms for consumers and patients for health and neuroplasticity

Translational Food Sciences 2025 Charles S. Brennan, Yanyi Huang, Margaret A. Brennan 3 citations

Abstract The use of mushrooms in health-promoting foods and substances is widely studied. There are compelling data to indicate that polysaccharides and phenolic compounds derived from mushroom sources have long-lasting metabolic effects when ingested. More recently, attention has returned to the traditional practices of using psychotropic bioactive ingredients obtained from mushrooms for the...

Toward Translatable Biomarkers of Psychedelic-Induced Neuroplasticity.

American Journal of Psychiatry 2025 David E. Olson 8 citations

Numerous preclinical studies have demonstrated that psychedelics promote the growth of cortical neurons in the prefrontal cortex. However, measuring psychedelic-induced structural plasticity in humans has remained a challenge. New advances in positron emission tomography imaging could facilitate the measurement of synaptic proteins in humans following psychedelic administration. Identifying a...

DOI: 10.1176/appi.ajp.20231054 (opens in new tab) Full text (opens in new tab) Ketamine Sv2a Psychoplastogen Psychedelics/hallucinogens/entheogens +3

Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity.

Neuropsychiatric Disease and Treatment 2025 Daniel A Kinderlehrer 13 citations

The incidence of mental health disorders is increasing worldwide. While there are multiple factors contributing to this problem, neuroinflammation underlies a significant subset of psychiatric conditions, particularly major depressive and anxiety disorders. Anti-inflammatory interventions have demonstrated benefit in these conditions. Psilocin, the active ingredient of mushrooms in the...

Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review.

Mol Med December 19, 2024 Rafael V Lima Da Cruz, Richardson N. Leão, Thiago C. Moulin 13 citations

In the mammalian brain, new neurons continue to be generated throughout life in a process known as adult neurogenesis. The role of adult-generated neurons has been broadly studied across laboratories, and mounting evidence suggests a strong link to the HPA axis and concomitant dysregulations in patients diagnosed with mood disorders. Psychedelic compounds, such as phenethylamines, tryptamines,...

Effects of serotonin agonists LSD and 25CN-NBOH on conditioned place preference and on synaptic plasticity of VTA dopamine neurons in mice

bioRxiv Preprint Server December 12, 2024 Lauri Elsilä, Elina Nagaeva, Jari-Pekka Luukkonen et al. 1 citation preprint

The current research on psychedelic compounds such as lysergic amide diethylamide (LSD) is leaning heavily on the notion that psychedelics are not addictive. While much of the literature supports this argument, some of the common use patterns and the descriptions of the subjective effects of these compounds in humans, together with rather lacking and mixed data from non-human animal studies...

Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder.

Molecular Psychiatry December 1, 2024 Chloe E Page, C Neill Epperson, Andrew M Novick et al. 54 citations

The serotonin deficit hypothesis explanation for major depressive disorder (MDD) has persisted among clinicians and the general public alike despite insufficient supporting evidence. To combat rising mental health crises and eroding public trust in science and medicine, researchers and clinicians must be able to communicate to patients and the public an updated framework of MDD: one that is (1)...

Neuroplasticity and Psychedelics: a comprehensive examination of classic and non-classic compounds in pre and clinical models

arXiv Preprint Archive November 29, 2024 Claudio Agnorelli, Meg J. Spriggs, Kate Godfrey et al. 32 citations preprint

Neuroplasticity, the ability of the nervous system to adapt throughout an organism's lifespan, offers potential as both a biomarker and treatment target for neuropsychiatric conditions. Psychedelics, a burgeoning category of drugs, are increasingly prominent in psychiatric research, prompting inquiries into their mechanisms of action. Distinguishing themselves from traditional medications,...

Full text (opens in new tab) Neuroplasticity Q-bio.nc Q-bio.bm Psychopharmacology +1

S-ketamine alleviates depression-like behavior and hippocampal neuroplasticity in the offspring of mice that experience prenatal stress.

Scientific Reports November 6, 2024 Yan Zhang, Chu-Ke Wei, Ping Wang et al. 12 citations

Prenatal stress exerts long-term impact on neurodevelopment in the offspring, with consequences such as increasing the offspring's risk of depression in adolescence and early adulthood. S-ketamine can produce rapid and robust antidepressant effects, but it is not clear yet whether and how S-ketamine alleviates depression in prenatally stressed offspring. The current study incestigated the...

Ketamine induced synaptic plasticity operates independently of long-term potentiation.

Neuropsychopharmacology October 1, 2024 Michelle K Piazza, Ege T Kavalali, Lisa M Monteggia 21 citations

Synaptic plasticity occurs via multiple mechanisms to regulate synaptic efficacy. Homeostatic and Hebbian plasticity are two such mechanisms by which neuronal synapses can be altered. Although these two processes are mechanistically distinct, they converge on downstream regulation of AMPA receptor activity to modify glutamatergic neurotransmission. However, much remains to be explored regarding...